UiPath saw an improvement in its IBD SmartSelect Composite Rating Friday, from 93 to 99.
The new score tells you the company is now outperforming 99% of all stocks in terms of the most important fundamental and technical stock-picking criteria.
UiPath is currently forming a double bottom, with a 19.03 buy point. After yesterday's earnings report it had a big move, which is continuing today. See if the stock can break through the pivot point in volume higher than normal.
See How IBD Helps You Make More Money In Stocks
The stock has an 81 EPS Rating, meaning its recent quarterly and longer-term annual earnings growth tops 81% of all stocks.
Its Accumulation/Distribution Rating of C- shows a roughly equal amount of buying and selling by institutional investors over the last 13 weeks.
The company reported a 0% increase in earnings for Q2. Top line growth climbed 19%, up from 18% in the prior quarter. That marks two consecutive reports with rising growth.
UiPath holds the No. 2 rank among its peers in the Computer Software-Enterprise industry group. ServiceNow is the top-ranked stock within the group.
Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks
